TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 295 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,203 | +270.3% | 336,324 | +276.0% | 0.35% | +272.0% |
| Q2 2023 | $1,405 | -99.9% | 89,438 | -29.7% | 0.09% | -40.4% |
| Q3 2021 | $2,084,000 | +2.9% | 127,237 | +5.8% | 0.16% | +28.9% |
| Q2 2021 | $2,025,000 | -14.3% | 120,310 | -7.0% | 0.12% | -19.9% |
| Q1 2021 | $2,363,000 | -35.7% | 129,425 | -35.9% | 0.15% | -58.9% |
| Q4 2020 | $3,676,000 | +71.2% | 202,002 | +67.9% | 0.37% | +65.3% |
| Q3 2020 | $2,147,000 | +52.7% | 120,322 | +53.4% | 0.22% | +37.0% |
| Q2 2020 | $1,406,000 | – | 78,436 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |